SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-009485
Filing Date
2023-03-23
Accepted
2023-03-23 16:09:22
Documents
13
Period of Report
2023-03-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sbtx-20230323.htm   iXBRL 8-K 79818
2 EX-99.1 sbtx-ex99_1.htm EX-99 268501
  Complete submission text file 0000950170-23-009485.txt   491401

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sbtx-20230323.xsd EX-101.SCH 2474
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sbtx-20230323_lab.xml EX-101.LAB 18676
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sbtx-20230323_pre.xml EX-101.PRE 11560
7 EXTRACTED XBRL INSTANCE DOCUMENT sbtx-20230323_htm.xml XML 4893
Mailing Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130 858-771-9307
ARS Pharmaceuticals, Inc. (Filer) CIK: 0001671858 (see all company filings)

IRS No.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39756 | Film No.: 23756283
SIC: 2834 Pharmaceutical Preparations